FDA approves Telix brain cancer imaging drug Pixclara
Telix said the FDA approved its brain cancer imaging drug Pixclara, with the stock up in premarket trading.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.